Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
04/19/2024 10:37 PM
Pennsylvania House of Representatives
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=H&SPick=20190&cosponId=29158
Share:
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


House of Representatives
Session of 2019 - 2020 Regular Session

MEMORANDUM

Posted: April 8, 2019 03:14 PM
From: Representative Seth M. Grove
To: All House members
Subject: Updating the Pharmacy and Therapeutics Committee
 
In the near future, I plan to introduce legislation making updates to the current membership of the Pharmacy and Therapeutics (P & T) Committee within the Department of Human Services (DHS).

The department created the P&T Committee to act in an advisory capacity to DHS and the Office of Medical Assistance Programs. The committee also makes recommendations relating to the department’s Preferred Drug List (PDL) used for purchasing drugs through the state’s Medical Assistance program (Medicaid). The recommendations made by the committee include new drugs for existing classes under the PDL, changes in the status of drugs on the PDL, new quantity limits and classes of drugs to be added to or deleted from the PDL.

Currently, the committee is comprised of medical directors from DHS along with external physicians and pharmacists from managed care organizations. My legislation would expand the committee to include both legislators and community pharmacists. This expansion will ensure the committee has a balanced perspective as they recommend medications purchased by taxpayers through Medicaid and delivered to our most vulnerable individuals.

The work the P & T Committee does is extremely important which is why the committee should include members from the legislature to ensure appropriate oversight. The committee should also be expanded to include community pharmacists as they are the ones on the “front line” who see the impact of pharmaceutical decisions on patients.

Please join me in cosponsoring this important legislation.

View Attachment


Introduced as HB942